Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year's End

FinancialNewsMedia.com News Commentary

PALM BEACH, Fla., Aug. 9, 2023 /PRNewswire/ -- About 9.4% of the world population is aged 65 or above. Older people typically consume more medicines than the people in other age group thereby creating the demand for new, improved or less costly pharmaceuticals. This trend has been continuously growing for the past several years and is projected to continue for years to come. Further, new diseases including mutated forms of old diseases are also mounting. Urbanization and industrialization have led global movement of people and thereby introduction of new pathogens spreading at very high rate. Few such examples are SARS and Covid-19.  Pharmaceuticals (biopharma, drug, medicine) are defined as any substance intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease or any substance (other than food) intended to affect the structure or function of the body. Drugs are produced in forms such as pills, tablets, capsules, etc. Pharmaceuticals (biopharma, drug, medicine) are defined as any substance intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease or any substance (other than food) intended to affect the structure or function of the body. Drugs are produced in forms such as pills, tablets, capsules, etc. Generic drugs are copies of innovative pharmaceuticals that contain the same active ingredients and are identical in strength, dosage form and route of administration and are comparatively cheaper than the innovative ones.  Nearly, 40% of the all prescription drugs purchases were generic drug category. The generic-drug business model is based on high-volume treatments that target larger population.  A report from Reogma.com projected that the global market for pharmaceuticals will grow by 4-5% CAGR, reaching USD $1.5 trillion by 2023.  Active Biotech Companies active today in markets include:  Palatin Technologies, Inc. (NYSE:PTN), Cardiff Oncology, Inc. (NASDAQ:CRDF), Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), Bright Minds Biosciences Inc. (NASDAQ:DRUG), Eli Lilly and Company (NYSE:LLY).